2 Promising Stocks That Are Screaming Buys in June
While 2022 was disastrous for much of the market, 2023 is shaping up to be much better, with the S 500 already up nearly 15% so far this year. Long-term investors understand that these ups and downs are just the cost of trading stocks and that the market and risk are inextricably linked. That's why buying (and then holding) stocks of resilient companies that can weather the inevitable market highs and lows and keep moving forward is a proven long-term strategy for profitable returns.
Two companies being featured today operate in high-growth industries with plenty of opportunity for expansion. And their stocks trade at a discount right now. Let's look at why these two magnificent stocks are such screaming buys this month.
Medical device manufacturer (NYSE: MDT) has a knack for maintaining business stability, especially in challenging years for the market. It sells medical devices all over the world, helping treat 70 different medical conditions. It operates in four product categories: cardiovascular, medical-surgical, neuroscience, and diabetes. The global medical device market is definitely in expansion mode, with a compound annual growth rate of 5.5% expected between 2022 and 2029. Medtronic, with its diverse portfolio, has the opportunity to capture more than its fair share of that future growth.
Source Fool.com
Medtronic plc Aktie
Eine Tendenz zu Buy-Einschätzungen bei Medtronic plc, überwiegend gegenüber Sell-Einschätzungen.
Ein Kursziel von 94 € für Medtronic plc zeigt ein leicht positives Potenzial im Vergleich zum aktuellen Kurs von 81.1 €.